Ascendis leads latest pack of follow-ons with $600M raise

Four therapeutics companies raised nearly $1.2 billion in follow-ons after market close Tuesday, signaling sustained investor demand for biotech holdings.

The four biotechs proposed their offerings Tuesday morning, and three priced at a premium...